GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Presentation at Singapore Conference

20 Sep 2012 07:00

RNS Number : 6887M
ViaLogy PLC
20 September 2012
 



VIALOGY PLC ("VIALOGY")

VIALOGY PRESENTS NEW CAPABILITY FOR INCREASING PRIMARY RECOVERY

IN TIGHT CARBONATES AT AAPG SINGAPORE CONFERENCE

 

Pasadena, CA, September 20, 2012. ViaLogy PLC (LSE/AIM: VIY).At a major international energy industry conference today, ViaLogy presented results of work performed for Chevron showing how QuantumRD, its proprietary seismic analysis technology, could significantly increase primary recovery of oil over currently achieved yields in tight carbonate formations. The Chevron-approved presentation to the American Association of Petroleum Geologists (AAPG) in Singapore also provided more details about ViaLogy's current analysis work for the energy supermajor.

In an extensive test analysis, completed earlier this year, ViaLogy's QuantumRD technology was applied to a Chevron 3D seismic dataset to delineate porosity trends in the tight dolomite formations of the lower Permian Basin. The ability to predict effective carbonate porosity in such formations is central to positioning wells and geosteering for horizontal wells. In the blinded test, QuantumRD located the porosity trend that corresponded to the highest producing wells in the formation, something not previously achieved by using best-of-breed conventional analysis or geostatistical software. ViaLogy actually predicted porosity 2 to 3 miles away from known wells, using information that was below the resolution of the seismic data, and that was verified by comparison with the ground truth derived from over 300 wells in the project area.

Other conclusions from the study presented in Singapore were porosity prediction at 20 feet vertical resolution representing a twofold increase in resolution over conventional inversion and geostatistical techniques applied to similar formations.

Utilizing the QuantumRD method could result in a significant reduction of the number of infill wells drilled using standard gridding techniques while increasing recovery from optimally placed wells, thus saving considerable capital expenditure costs. In fact, the study concluded that 40% of poorly performing wells or dry holes drilled using grid-based placement could have been avoided.

ViaLogy CEO Dr. Robert Dean commented, "We regard the results of our work for Chevron as a very important step in establishing QuantumRD as a technology that will be of great value to the upstream Exploration and Production sector. We believe it to be a key improvement over available techniques, and that its widespread use could achieve major savings in the development and production cycle. The dollar value of QuantumRD is to improve primary yields from production areas such as the Permian Basin that are comprised of multiple tight zones. Also importantly, QuantumRD processing could infuse new life into older, expensively acquired seismic surveys that are known to hold promise for large reserves. ViaLogy is dedicated to realizing this potential. Our current work for Chevron and other companies should provide more examples of operating efficiencies in the coming months."

 

For further information contact: 

ViaLogy

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy/Catherine Leftley, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner, Corporate Broking +44 (0) 20-7107-8000

 

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery. ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGMLVLZGZZM
Date   Source Headline
1st Aug 202310:32 amRNSForm 8.3 - Yourgene Health PLC
1st Aug 20239:23 amRNSForm 8.5 (EPT/RI)
31st Jul 202310:59 amRNSForm 8.3 - Yourgene Health PLC
31st Jul 20239:38 amRNSForm 8.5 (EPT/RI)
28th Jul 202310:53 amRNSForm 8.5 (EPT/RI)
27th Jul 20237:00 amRNSPublication of Scheme Document & current trading
26th Jul 20234:45 pmRNSForm 8.3 - Yourgene Health plc
26th Jul 202310:12 amRNSForm 8.5 (EPT/RI)
26th Jul 20238:45 amRNSForm 8.3 - YOURGENE HEALTH PLC
26th Jul 20237:00 amRNSFive-year contract extension with Illumina
25th Jul 20232:06 pmRNSForm 8.3 - Yourgene Health plc
25th Jul 20239:48 amRNSForm 8.5 (EPT/RI) - Yourgene Health PLC
25th Jul 20237:00 amRNSForm 8.3 - Yourgene Health Plc
24th Jul 20238:32 amRNSForm 8.3 - Yourgene Health PLC
21st Jul 20238:59 amRNSForm 8.5 (EPT/RI)
20th Jul 202311:44 amRNSForm 8.5 (EPT/RI)
19th Jul 20232:06 pmRNSForm 8.3 - Yourgene Health plc
19th Jul 202312:21 pmRNSRule 2.9 Announcement
19th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
19th Jul 20237:00 amRNSIssue of equity, cancellation of warrants & TVR
18th Jul 20235:15 pmRNSForm 8.5 (EPT/RI) Replacement - Yourgene Health PL
18th Jul 20235:13 pmRNSForm 8.3 - YourGene Health plc
18th Jul 20235:00 pmRNSForm 8.5 (EPT/RI) Replacement
18th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
18th Jul 20238:39 amRNSForm 8.3 - Yourgene Health PLC
17th Jul 20235:00 pmRNSForm 8.3 - Yourgene Health Plc
17th Jul 202312:00 pmRNSForm 8.5 (EPT/RI)
17th Jul 202310:27 amRNSForm 8.5 (EPT/RI)
17th Jul 20239:05 amRNSForm 8.3 - Yourgene Health PLC
17th Jul 20238:15 amRNSForm 8.3 - YOURGENE HEALTH PLC
14th Jul 20232:02 pmRNSForm 8.3 - Yourgene Health plc
14th Jul 202312:02 pmRNSForm 8.5 (EPT/RI)
14th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
14th Jul 202310:36 amRNSForm 8.3 - YOURGENE HEALTH PLC
13th Jul 20235:02 pmRNSForm 8.3 - Yourgene Health PLC - Correction
13th Jul 20234:29 pmRNSForm 8 (OPD) (Yourgene Health Plc)
13th Jul 20232:03 pmRNSForm 8.3 - Yourgene Health plc
13th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
13th Jul 202310:43 amRNSForm 8.3 - Yourgene Health Plc
13th Jul 202310:17 amRNSForm 8.5 (EPT/RI)
13th Jul 20239:02 amRNSForm 8.3 - Yourgene Health PLC
13th Jul 20238:53 amRNSForm 8.3 - Yourgene Health PLC
12th Jul 20232:04 pmRNSForm 8.3 - Yourgene Health plc
12th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
12th Jul 202311:39 amRNSForm 8.3 - Yourgene Health PLC
12th Jul 20239:21 amRNSForm 8.5 (EPT/RI)
12th Jul 20238:44 amRNSForm 8.3 - Yourgene Health PLC
12th Jul 20238:18 amRNSForm 8.3 - Yourgene Health PLC
11th Jul 20232:20 pmRNSForm 8.3 - Yourgene Health plc
11th Jul 202312:46 pmRNSForm 8.3 - Yourgene Health PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.